Clinical Trial Update: Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts [Phase 1, Phase 2]

View source ↗

Summary

Results from a Phase 1/2 study evaluating the combination of blinatumomab and pembrolizumab in adults with relapsed/refractory B-cell acute lymphoblastic leukem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University of California, San Diego | Conditions: B-Cell Acute Lymphoblastic Leukemia, Adult | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-11-10